|
Conley, Robert R; Ascher-Svanum, Haya; Zhu, Baojin et al. (2007) The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res 90:186-97
|
|
Carpenter, William T; Conley, Robert R (2007) Challenge to atypical antipsychotic drug effect on cognition. Am J Psychiatry 164:1910-1;author reply 1911-2
|
|
Kelly, Deanna L; Richardson, Charles M; Yu, Yang et al. (2006) Plasma concentrations of high-dose olanzapine in a double-blind crossover study. Hum Psychopharmacol 21:393-8
|
|
Kelly, Deanna L; Conley, Robert R (2006) A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology 31:340-6
|
|
Conley, Robert R; Kelly, Deanna L; Nelson, Matthew W et al. (2005) Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia. Clin Neuropharmacol 28:163-8
|
|
Conley, Robert R; Kelly, Deanna L (2005) Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects. Isr J Psychiatry Relat Sci 42:51-60
|
|
McMahon, Robert P; Arndt, Stephan; Conley, Robert R (2005) More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk. Stat Med 24:11-21
|
|
Conley, Robert R; Shim, Joo-Cheol; Kelly, Deanna L et al. (2005) Cardiovascular disease in relation to weight in deceased persons with schizophrenia. Compr Psychiatry 46:460-7
|
|
Kelly, Deanna L; Conley, Robert R (2005) Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. J Clin Psychiatry 66:80-4
|
|
Wilk, Christopher M; Gold, James M; Humber, Kathy et al. (2004) Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status. Schizophr Res 70:175-86
|
Showing the most recent 10 out of 20 publications
